ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 777 participants.
Also called NCT01757665
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 777 participants
- Sponsor
- Registry
-
NCT01757665
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Poland
- Registry status
- Completed
Technical summary
Registry record NCT01757665. Allocation not applicable; no masking; primary purpose treatment. Start 2012-12-11 (actual); primary completion 2017-08 (actual). Results posted on 2019-12-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
- Acronym
- COMMENCE
- Condition
- Aortic Stenosis
- Condition
- Mitral Stenosis
- Condition
- Aortic Valve Insufficiency
- Condition
- Mitral Valve Insufficiency
- Condition
- Heart Failure
- Intervention (Device)
- Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct01757665- Content hash
981d52bbae10dec9731b196a7dc5485c36bce0a066b962eb1ffb148a9c79274b